cGMP-independent nitric oxide signaling and regulation of the cell cycle

BMC Genomics. 2005 Nov 3:6:151. doi: 10.1186/1471-2164-6-151.

Abstract

Background: Regulatory functions of nitric oxide (NO*) that bypass the second messenger cGMP are incompletely understood. Here, cGMP-independent effects of NO* on gene expression were globally examined in U937 cells, a human monoblastoid line that constitutively lacks soluble guanylate cyclase. Differentiated U937 cells (>80% in G0/G1) were exposed to S-nitrosoglutathione, a NO* donor, or glutathione alone (control) for 6 h without or with dibutyryl-cAMP (Bt2cAMP), and then harvested to extract total RNA for microarray analysis. Bt2cAMP was used to block signaling attributable to NO*-induced decreases in cAMP.

Results: NO* regulated 110 transcripts that annotated disproportionately to the cell cycle and cell proliferation (47/110, 43%) and more frequently than expected contained AU-rich, post-transcriptional regulatory elements (ARE). Bt2cAMP regulated 106 genes; cell cycle gene enrichment did not reach significance. Like NO*, Bt2cAMP was associated with ARE-containing transcripts. A comparison of NO* and Bt2cAMP effects showed that NO* regulation of cell cycle genes was independent of its ability to interfere with cAMP signaling. Cell cycle genes induced by NO* annotated to G1/S (7/8) and included E2F1 and p21/Waf1/Cip1; 6 of these 7 were E2F target genes involved in G1/S transition. Repressed genes were G2/M associated (24/27); 8 of 27 were known targets of p21. E2F1 mRNA and protein were increased by NO*, as was E2F1 binding to E2F promoter elements. NO* activated p38 MAPK, stabilizing p21 mRNA (an ARE-containing transcript) and increasing p21 protein; this increased protein binding to CDE/CHR promoter sites of p21 target genes, repressing key G2/M phase genes, and increasing the proportion of cells in G2/M.

Conclusion: NO* coordinates a highly integrated program of cell cycle arrest that regulates a large number of genes, but does not require signaling through cGMP. In humans, antiproliferative effects of NO* may rely substantially on cGMP-independent mechanisms. Stress kinase signaling and alterations in mRNA stability appear to be major pathways by which NO* regulates the transcriptome.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Blotting, Western
  • Cell Cycle
  • Cell Proliferation
  • Cyclic AMP / metabolism
  • Cyclic GMP / metabolism*
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • E2F1 Transcription Factor / metabolism
  • Gene Expression Regulation, Enzymologic*
  • Glutathione / metabolism
  • Humans
  • MAP Kinase Signaling System
  • Models, Biological
  • Models, Statistical
  • Nitric Oxide / metabolism*
  • Oligonucleotide Array Sequence Analysis
  • Phosphorylation
  • Promoter Regions, Genetic
  • RNA / metabolism
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • S-Nitrosoglutathione / metabolism
  • Signal Transduction*
  • Time Factors
  • Transcription, Genetic
  • U937 Cells
  • Up-Regulation

Substances

  • Cyclin-Dependent Kinase Inhibitor p21
  • E2F1 Transcription Factor
  • RNA, Messenger
  • Nitric Oxide
  • S-Nitrosoglutathione
  • RNA
  • Cyclic AMP
  • Glutathione
  • Cyclic GMP